BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4251393)

  • 1. Immunologic enhancement induced by antibody fragments.
    Cruse JM; Forbes JT; Gillespie GY; Lewis GK
    Z Immunitatsforsch Allerg Klin Immunol; 1970; 140(3):259-67. PubMed ID: 4251393
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF; Snell GD
    Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
    [No Abstract]   [Full Text] [Related]  

  • 3. Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2 in vitro.
    Cruse JM; Whitten HD; Lewis GK; Watson ES
    Transplant Proc; 1973 Mar; 5(1):961-7. PubMed ID: 4695960
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunochemical and biologic characterization of alloantibody active in immunologic enhancement.
    Fuller TC; Winn HJ
    Transplant Proc; 1973 Mar; 5(1):585-7. PubMed ID: 4695953
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunologic enhancement induced by 7S antibody globulin.
    Cruse JM; Azar MM
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Mar; 132(3):240-6. PubMed ID: 4232737
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of human F(ab') 2 fragments as blocking agents in the mixed lymphocyte reaction.
    Hornung MO; Layne E; McDonald JC
    J Immunol; 1971 Oct; 107(4):979-84. PubMed ID: 4999263
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of immunologic enhancement.
    Amos DB; Cohen I; Klein WJ
    Transplant Proc; 1970 Mar; 2(1):68-75. PubMed ID: 4107294
    [No Abstract]   [Full Text] [Related]  

  • 8. Active or passive enhancement and allograft survival.
    Wilson RE
    Transplant Proc; 1972 Dec; 4(4):513-5. PubMed ID: 4405144
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic enhancement in a syngeneic tumor system.
    Beltz WR; Levy NL
    Surg Forum; 1975; 26():142-4. PubMed ID: 1216091
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphocyte-antibody interactions in immunological enhancement.
    Takasugi M; Hildemann WH
    Transplant Proc; 1969 Mar; 1(1):530-4. PubMed ID: 5406837
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigen driven selection for Fc receptors of enhancing antibody on macrophages during an alloimmune response.
    Whitten HD; Cruse JM; Lewis GK; Watson ES
    J Reticuloendothel Soc; 1974 Feb; 15(2):118-25. PubMed ID: 4815211
    [No Abstract]   [Full Text] [Related]  

  • 12. Soluble mouse histocompatibility antigens.
    Koene R; McKenzie IF; Painter E; Sachs DH; Winn HJ; Russell PS
    Transplant Proc; 1971 Mar; 3(1):231-3. PubMed ID: 4106314
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J
    Ser Haematol; 1972; 5(4):93-122. PubMed ID: 4133765
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytotoxic lymphocytes and anti-tumor immunity].
    Cerottini JC; Brunner KT
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of immunological enhancement.
    Cruse JM; Lewis GK; Whitten HD; Watson ES; Fields JF; Adams ST; Harvey GF; Paslay JW; Porter M
    Prog Exp Tumor Res; 1974; 19():110-56. PubMed ID: 4140539
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancement and antigen suicide in the outbred primate.
    Myburgh JA; Smit JA
    Transplant Proc; 1973 Mar; 5(1):597-600. PubMed ID: 4633092
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody turnover by enhanced rat kidneys.
    French ME
    Transplant Proc; 1973 Mar; 5(1):621-3. PubMed ID: 4572122
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immune reaction of autochthonous tumor--analysis of cellular immunity in rejection of methylcholanthrene-induced autochthonous tumor].
    Kikuchi K; Kikuchi Y
    Saishin Igaku; 1971 Nov; 26(11):2170-9. PubMed ID: 5141954
    [No Abstract]   [Full Text] [Related]  

  • 20. A synergistic immunosuppressive effect of endotoxin and PHA-M on immunologic enhancement in mice.
    Cruse JM; Forbes JT; Shivers BR; Gillespie GY; Lewis GK; Scales RW; Fields JF; Hester RB; Watson ES; Whitten HD
    Z Immunitatsforsch Exp Klin Immunol; 1972 Jan; 143(1):31-42. PubMed ID: 4282905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.